Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rory Riggs Insider Profile
11 Followers
Rory Riggs, Director at FibroGen, holds 99.50K shares in Intra-Cellular Therapies (Ticker: ITCI), holds 420.29K shares in Royalty Pharma (Ticker: RPRX), holds 3.14M shares in Cibus (Ticker: CBUS).
Profitable Transactions
16 out of 29 Profitable Transactions
Average Return
+0.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rory Riggs holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rory Riggs
Rory Riggs's Trading History
FibroGen
May 28, 2021
Director
Uninformative Buy
―
$1.07M
Royalty Pharma
Feb 22, 2024
Director
Uninformative Buy
―
$11.69M
Cibus
Jan 03, 2024
CEO, Director, Ten Percent Owner
Uninformative Buy
―
$50.26M
Intra-Cellular Therapies
Apr 02, 2024
Director
Uninformative Buy
17.99K
$7.36M
List of latest transactions for each holding click on a transaction to see Rory Riggs's performance on stock
You May Also Like
Rory Riggs insider profile FAQ
What is the percentage of profitable transactions made by Rory Riggs?
The percentage of profitable transactions made by Rory Riggs is 55%.
What is the average return per transaction made by Rory Riggs?
The average return per transaction made by Rory Riggs is 0.20%.
What stocks does Rory Riggs hold?
Rory Riggs holds: FGEN, RPRX, CBUS, ITCI stocks.
What was Rory Riggs’s latest transaction?
Rory Riggs latest transaction was an Uninformative Buy of $17.99K.
What was Rory Riggs's most profitable transaction?
Rory Riggs’s most profitable transaction was an Informative Sell of RPRX stock on November 21, 2022. The return on the trade was 35.40%.
What is Rory Riggs's role in FibroGen?
Rory Riggs's role in FibroGen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.